Angiotensin converting enzyme inhibition improves baroreflex-induced noradrenaline spillover responses in rabbits with heart failure

Journal of the Autonomic Nervous System

Volumn 66, Issue 1-2, 1997, Pages 87-93

  Noshiro, Takao ^a,b   Way, Diana ^a   McGrath, Barry P ^a  

^a MONASH UNIVERSITY   (Australia)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Doxorubicin; Enalaprilat; Kidney; Phenylephrine; Sodium nitroprusside

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXORUBICIN; ENALAPRILAT; NITROPRUSSIDE SODIUM; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; HEART RATE; INTRAVENOUS DRUG ADMINISTRATION; MEAN ARTERIAL PRESSURE; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RABBIT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ADRENERGIC ALPHA-AGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BAROREFLEX; BLOOD PRESSURE; DOXORUBICIN; ENALAPRILAT; HEART FAILURE, CONGESTIVE; HEART RATE; NITROPRUSSIDE; NOREPINEPHRINE; PHENYLEPHRINE; RABBITS; REGIONAL BLOOD FLOW; RENAL CIRCULATION; RENIN-ANGIOTENSIN SYSTEM;

EID: 0031563514     PISSN: 01651838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1838(97)00068-4     Document Type: Article

References (41)

1. Arnolda L., McGrath B.P., Cocks M., Sumithran E., Johnston C.I. Adriamycin cardiomyopathy in the rabbit: An animal model of low output cardiac failure with activation of vasoconstrictor mechanisms. Cardiovasc. Res. 19:1985;378-382.
2. Arnolda L., McGrath B.P., Cocks M., Johnston C.I. Vasoconstrictor role for vasopressin in experimental heart failure in the rabbit. J. Clin. Invest. 78:1986;674-679.
3. Brändle M., Wang W., Zucker I.H. Ventricular mechanoreflex and chemoreflex alterations in chronic heart failure. Circ. Res. 74:1994;262-270.
4. Brooks V.L., Reid I.A. Interaction between angiotensin II and the baroreceptor reflex in the control of adrenocorticotropic hormone secretion and heart rate in conscious dogs. Circ. Res. 58:1986;816-828.
5. Cody R.J., Franklin K.W., Kluger J., Laragh J.H. Mechanisms governing the postural response and baroreceptor abnormalities in chronic congestive heart failure: Effects of acute and long-term converting-enzyme inhibition. Circulation. 66:1982;135-142.
6. Cohn J.N., Johnson G., Ziesche S. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. New Engl. J. Med. 325:1991;303-310.
7. Creager M.A., Halperin J.L., Bernard D.B. Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure. Circulation. 64:1981;483-489.
8. Deedwania P.C. Angiotensin-converting enzyme inhibitors in congestive heart failure. Arch. Intern. Med. 150:1990;1798-1805.
9. Dibner-Dunlap M.E., Thames M.D. Baroreflex control of renal sympathetic nerve activity is preserved in heart failure despite reduced arterial baroreceptor sensitivity. Circ. Res. 65:1989;1526-1535.
10. DiBona G.F. The functions of the renal nerves. Rev. Physiol. Biochem. Pharmacol. 94:1982;75-181.
11. Dzau V.J. Renal and circulatory mechanisms in congestive heart failure. Kidney Int. 31:1987;1402-1415.
12. Ellenbogen K.A., Mohanty P.K., Szentpetery S., Thames M.D. Arterial baroreflex abnormalities in heart failure: Reversal after orthotopic cardiac transplantation. Circulation. 79:1989;51-58.
13. Elliott J.M., Kapoor V., Cain M., West M.J., Chalmers J.P. The mechanism of hypertension and bradycardia following lesions of the caudal ventrolateral medulla in the rabbit: The role of sympathetic nerves, circulating adrenaline, vasopressin and renin. Clin. Exp. Hypertens. A7:1985;1059-1082.
14. Esler M.et al. Determination of noradrenaline apparent release rate and clearance in humans. Life Sci. 25:1979;1461-1470.
15. Esler M., Blombery P., Leonard P., Jennings G., Korner P. Radiotracer methodology for the simultaneous estimation of total, and renal, sympathetic nervous system activity in humans. Clin. Sci. 63:1982;285s-287s.
16. Ferguson D.W. Sympathetic mechanisms in heart failure: Pathophysiological and pharmacological implications. Circulation. 87 (Suppl. VII):1993;VII68-VII75.
17. Gottlieb S.S., Weir M.R. Renal effects of angiotensin-converting enzyme inhibition in congestive heart failure. Am. J. Cardiol. 66:1990;14D-21D.
18. Higgins C.B., Vatner S.F., Eckberg D.L., Braunwald E. Alterations in the baroreceptor reflex in conscious dogs with heart failure. J. Clin. Invest. 51:1972;715-724.
19. Hirsch A.T., Dzau V.J., Creager M.A. Baroreceptor function in congestive heart failure: Effect on neurohumoral activation and regional vascular resistance. Circulation. 75 (Suppl. IV):1987;IV36-IV48.
20. Isaacson J.S., Reid I.A. Importance of endogenous angiotensin II in the cardiovascular responses to sympathetic stimulation in conscious rabbits. Circ. Res. 66:1990;662-671.
21. Kingwell B.A., McPherson G.A., Korner P.I. Assessment of gain of tachycardia and bradycardia responses of cardiac baroreflex. Am. J. Physiol. 260:1991;H1254-H1263.
22. Langton D., Jover B., McGrath B.P., Ludbrook J. Cardiovascular responses to graded treadmill exercise during development of doxorubicin induced heart failure in rabbits. Cardiovasc. Res. 24:1990;959-968.
23. McGrath B.P., Lim S.P., Leversha L., Shanahan A. Myocardial and peripheral catecholamine responses to acute coronary artery constriction before and after propranolol treatment in the anaesthetized dog. Cardiovasc. Res. 15:1981;28-34.
24. B.P. McGrath, B.F. Jover, L. Trigg, L.F. Arnolda, Adriamycin-induced cardiomyopathic heart failure in the rabbit, in: C. Kawai, W.H. Abelmann (Eds.), Cardiomyopathy Update 1: Pathogenesis of Myocarditis and Cardiomyopathy: Recent Experimental and Clinical Studies, University of Tokyo Press, Tokyo, 1987, pp. 121-133.
25. Matumura Y., Hasser E.M., Bishop V.S. Central effect of angiotensin II on baroreflex regulation in conscious rabbits. Am. J. Physiol. 256:1989;R694-R700.
26. Niebauer M., Zucker I.H. Static and dynamic responses of carotid sinus baroreceptors in dogs with chronic volume overload. J. Physiol. 369:1985;295-310.
27. Noshiro T., Saigusa T., Way D., Dorward P.K., McGrath B.P. Noradrenaline spillover faithfully reflects renal sympathetic nerve activity in conscious rabbits. Am. J. Physiol. 261:1991;F44-F50.
28. Noshiro T., Shimizu K., Way D., Miura Y., McGrath B.P. Angiotensin II enhances noradrenaline spillover during sympathetic activation in conscious rabbits. Am. J. Physiol. 266:1994;H1864-H1871.
29. Oster J.R., Materson B.J. Renal electrolyte complications of congestive heart failure and effects of therapy with angiotensin-converting enzyme inhibitors. Arch. Intern. Med. 152:1992;704-710.
30. Packer M. Neurohumoral interactions and adaptations in congestive heart failure. Circulation. 77:1988;721-730.
31. Packer M. Pathophysiology of chronic heart failure. Lancet. 340:1992;88-92.
32. Reid I.A., Chou L. Analysis of the action of angiotensin II on the baroreflex control of heart rate in conscious rabbits. Endocrinology. 126:1990;2749-2756.
33. Sano N., Way D., McGrath B.P. Renal sympathetic nerve activity measured by noradrenaline spillover rate across the kidney in conscious rabbits. Clin. Exp. Pharmacol. Physiol. 16:1989;319-322.
34. Sano N., Way D., McGrath B.P. Renal noradrenaline spillover and baroreflex responses in evolving heart failure. Am. J. Physiol. 258:1990;F1516-F1522.
35. Stein R.D., Stephenson R.B., Weaver L.C. Central actions of angiotensin II oppose baroreceptor-induced sympathoinhibition. Am. J. Physiol. 246:1984;R13-R19.
36. The CONSENSUS Trial Study Group Effects of enalapril on mortality in severe congestive heart failure: Results of Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). New Engl. J. Med. 316:1987;1429-1435.
37. The SOLVD investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. New Engl. J. Med. 325:1991;293-302.
38. Wang W., Chen J.S., Zucker I.H. Carotid sinus baroreceptor reflex in dogs with experimental heart failure. Circ. Res. 68:1991;1294-1301.
39. Wang W., McClain J.M., Zucker I.H. Aldosterone reduces baroreceptor discharge in the dog. Hypertension. 19:1992;270-277.
40. Waugh W.H., Beall P.T. Simplified measurement of p-aminohippurate and other arylamines in plasma and urine. Kidney Int. 5:1974;429-436.
41. White C.W. Abnormalities in baroreflex control of heart rate in canine heart failure. Am. J. Physiol. 240:1981;H793-H799.